in 14 of Spain’s 17 regions. The company specializes in home respiratory assistance, including oxygen therapy and the treatment of sleep apnea. In addition, Gasmedi produces and distributes medical gases to hospitals and clinics.
Air Liquide intends to pursue further the development of its home healthcare activities in Spain through its affiliates, by ensuring management continuity and by relying upon the expertise and commitment of its teams.
This acquisition is subject to the approval of the Spanish Competition Authority, and is expected to be completed in the 4th quarter of 2012.
Pascal Vinet, Vice President, Healthcare Global Operations and member of the Group Executive Committee, commented: “This acquisition will strengthen our position in home healthcare in Spain, where Air Liquide is already present. The combination of Gasmedi’s performance and its expertise, in addition to the innovation capacity of Air Liquide, will enable us to continue to develop our activities for the benefit of all our patients.
This acquisition confirms our leadership position in the European home healthcare market and illustrates the capacity of Air Liquide to stimulate organic growth but also to choose projects that create value, in the short as well as the long term. In just 25 years, we have built a model founded on expertise, innovation and long-term performance. Health is one of the Group’s growth drivers.”